APTABIO THERAPEUTICS INC. AptaBio Therapeutics Inc. Share Price
Equities
A293780
KR7293780003
Biotechnology & Medical Research
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5,650 KRW | -2.42% |
|
-2.25% | -37.57% |
| Sales 2022 | 48.35M 35.15K 2.93M | Sales 2023 | 324M 235K 19.62M | Capitalization | 202B 147M 12.22B |
|---|---|---|---|---|---|
| Net income 2022 | -10.56B -7.68M -640M | Net income 2023 | -19.1B -13.88M -1.16B | EV / Sales 2022 | 4,567 x |
| Net cash position 2022 | 16.65B 12.1M 1.01B | Net cash position 2023 | 38.95B 28.32M 2.36B | EV / Sales 2023 | 503 x |
| P/E ratio 2022 |
-22.5
x | P/E ratio 2023 |
-10.7
x | Employees | - |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 65.49% |
More Fundamentals
* Assessed data
More news
| 1 day | -2.42% | ||
| 1 week | -2.25% | ||
| Current month | -19.40% | ||
| 1 month | -12.81% | ||
| 3 months | -22.18% | ||
| 6 months | -26.24% | ||
| Current year | -37.57% |
1 week
5 630.00
6 120.00
1 month
5 600.007 530.00
Current year
4 935.009 520.00
1 year
4 935.0013 330.00
3 years
4 935.0062 100.00
5 years
4 935.0062 100.00
10 years
4 935.0062 100.00
| Managers | Title | Age | Since |
|---|---|---|---|
Su-Jin Lee
FOU | Founder | 55 | 24/09/24 |
Sung-Hwan Moon
PSD | President | 65 | - |
Jun-Hee Jung
DFI | Director of Finance/CFO | 54 | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Su-Jin Lee
FOU | Founder | 55 | 24/09/24 |
Jong-Nam Suh
BRD | Director/Board Member | 62 | - |
Sung-Hwan Moon
PSD | President | 65 | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26/24/26 | 5,650 | -2.42% | 28,078 |
| 25/24/25 | 5,790 | -1.53% | 15,779 |
| 24/24/24 | 5,880 | +0.51% | 24,743 |
| 23/24/23 | 5,850 | -0.85% | 23,659 |
| 22/24/22 | 5,900 | +2.08% | 31,653 |
End-of-day quote Korea S.E., April 26, 2024
More quotes
Aptabio Therapeutics Inc. is a Korea-based company that researches and develops new drugs. The Company is developing anti-cancer drugs, drugs for inflammatory and fibrotic diseases and diabetic complications drugs, among others.
Calendar
13/05/2024
- Q1 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| -37.57% | 91.53M | |
| -2.31% | 103B | |
| +0.56% | 95.28B | |
| +1.69% | 22.15B | |
| -17.37% | 21.02B | |
| -9.30% | 18.15B | |
| -41.01% | 16.74B | |
| -14.85% | 16.05B | |
| +3.21% | 13.68B | |
| +33.54% | 12.17B |
- Stock Market
- Equities
- A293780 Stock
